Thermo Fisher Scientific | TMO - Loan Capital


Thermo Fisher Scientific reported $40.07B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Agilent USD 3.05B 1000K Mar/2026
Becton, Dickinson and Co. USD 14.71B 2.21B Mar/2026
Bio Techne USD 200M 60M Mar/2026
Bio-Rad Laboratories USD 802.9M 398.8M Mar/2026
Boston Scientific USD 11.01B 19M Dec/2025
Bruker USD 1.66B 189.6M Mar/2026
Charles River Laboratories USD 2.66B 526.77M Mar/2026
Danaher USD 17.56B 855M Mar/2026
Dentsply International USD 2.01B 9M Mar/2026
Edwards Lifesciences USD 600M 1.7M Mar/2026
General Electric Aerospace USD 18.17B 634M Mar/2026
Henry Schein USD 2.33B 17M Mar/2026
Illumina USD 1.49B 0 Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 13.99B 105M Mar/2026
Laboratory Of America USD 5.9B 748.3M Mar/2026
Medtronic USD 27.88B 255M Dec/2025
Mettler Toledo International USD 2.16B 73.35M Mar/2026
Myriad Genetics USD 120.3M 400K Mar/2026
Olympus JPY 159.7B 61M Mar/2026
OraSure Technologies USD 100K 17K Dec/2025
Quest Diagnostics USD 5.16B 12M Mar/2026
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 2.63B 836K Mar/2026
Stryker USD 14.22B 635M Mar/2026
Thermo Fisher Scientific USD 40.07B 4.22B Mar/2026
Veracyte USD 0 0 Mar/2025
Waters USD 5.22B 3.81B Mar/2026
Zimmer Biomet Holdings USD 6.3B 636.9M Mar/2026